Skip to search formSkip to main contentSkip to account menu

antibody therapy

Known as: antibodies therapy, passive antibody therapy, antibody therapies 
Treatment with injections of antibodies to directly destroy specific, usually cancerous, cells or to stimulate the immune system to destroy those… 
National Institutes of Health

Related topics

Related topics

5 relations
Biological Response Modifier TherapyImmunoglobulin TherapyMonoclonal Antibody TherapyRadioimmunotherapy

Broader (1)

Immunotherapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells.
Review
2004
Review
2004
Targeting of Radio-Isotopes for Cancer Therapy
Treatment of patients with therapeutic monoclonal antibodies (mAbs) such as rituximab (Rituxan), an anti-CD20 mAb, or trastuzumab… 
Highly Cited
2003
Highly Cited
2003
CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
Immunostimulatory CpG oligodeoxynucleotides (ODNs) can enhance the therapeutic effect of monoclonal antibodies (mAbs) by… 
Highly Cited
2003
Highly Cited
2003
Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma.
The mechanisms of interaction between anti-CD40 monoclonal antibody (mAb) therapy and external beam irradiation were investigated… 
Review
2001
Review
2001
Bi-specific antibody therapy for the treatment of cancer.
Bi-specific antibodies (BsAbs) combine immune cell activation with tumor cell recognition as a result of which tumor cells are… 
Highly Cited
1999
Highly Cited
1999
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer.
Adjuvant Interferon (IFN) was given to increase tumor antigen expression and enhance localization with 131I-labeled CC49… 
Review
1999
Review
1999
Antibody therapy for treatment of multiple myeloma.
Monoclonal antibody therapy has emerged as a viable treatment option for patients with lymphoma and some leukemias. It is now… 
Highly Cited
1996
Highly Cited
1996
Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies
Highly Cited
1996
Highly Cited
1996
Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection
Herpes simplex virus type 1 (HSV-1) infection on the murine cornea induces an intense inflammatory response which can lead to… 
1987
1987
Effect of periodontal therapy on specific antibody responses to suspected periodontopathogens.
The effects of clinically successful periodontal therapy were studied in juvenile periodontitis (JP) and rapidly progressive… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)